| Identification | Back Directory | [Name]
2-[(4-Bromophenyl)methyl]-4,5-dihydro-4,4-dimethyloxazole | [CAS]
176324-85-9 | [Synonyms]
Bilastine impurity 42
2-[(4-Bromophenyl)methyl]-4,5-dihydro-4,4-dimethyloxazole
Oxazole, 2-[(4-bromophenyl)methyl]-4,5-dihydro-4,4-dimethyl- | [Molecular Formula]
C12H14BrNO | [MOL File]
176324-85-9.mol | [Molecular Weight]
268.15 |
| Chemical Properties | Back Directory | [Boiling point ]
326.5±25.0 °C(Predicted) | [density ]
1.36±0.1 g/cm3(Predicted) | [solubility ]
Dichloromethane; | [form ]
Solid | [pka]
5.24±0.70(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
2-[(4-Bromophenyl)methyl]-4,5-dihydro-4,4-dimethyloxazole is an intermediate used in the synthesis of Bilastine-d6 (B385002), which is labelled Bilastine. It is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|